Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

MHRA recalls Beconase Aqueous Nasal Spray, Gliclazide 40 mg tablets

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 3 FMD medicines recall for Beconase Aqueous Nasal Spray and a class 2 pharmacy level recall for Gliclazide 40 mg Tablets.

Glaxo Wellcome UK Ltd T/A GSK is recalling the Beconase Aqueous Nasal Spray with batch number K84X, due to an issue related to error in the decommissioning.


This is the first falsified medicine directive (FMD) recall since July 2019.

“Upon decommissioning at the pharmacy and when scanning the serialised 2D code, the status of packs may report as ‘DESTROYED’,” the MHRA statement read.

Batch NumberExpiry DatePack SizeFirst Distributed
K84X09-2021106-Jan-2020

Accord UK is recalling all unexpired stock of Gliclazide 40 mg Tablets in Northstar Livery with batch number GU50 from pharmacies and wholesalers as a precautionary measure due to out of specification results for dissolution, obtained during routine stability testing.

Batch NumberExpiry DatePack SizeFirst Distributed
GU50Dec 20202824/05/2019

Pharmacists are asked to stop supplying both products immediately, quarantine remaining stock and return it to the supplier using the approved process.

The government agency also issued a class 4 pharmacy level caution in use for 13 batches of Atrolak (Quetiapine) prolonged release tablets by Accord, as the Patient Information Leaflet (PIL) within the packs are missing the side effects identified from post-marketing experience.

Pharmacists are adviced to ensure that patients are of any missing information and issue the current PILs with special warnings and precautions while dispensing the product.

Atrolak XL 50mg prolonged release tablets PL 20075/0213

Batch NumberExpiry DatePack SizeFirst Distributed
32272905/20216019 December 2019
Y0645510/20216003 September 2019

Atrolak XL 150mg prolonged release tablets PL 20075/0446

Batch NumberExpiry DatePack SizeFirst Distributed
Y0477110/20216006 November 2019
Y0478810/20216027 September 2019
Y0237405/20216007 August 2019

Atrolak XL 200mg prolonged release tablets PL 20075/0214

Batch NumberExpiry DatePack SizeFirst Distributed
X1765302/20216024 November 2019
Y0671008/20216018 November 2019

Atrolak XL 300mg prolonged release tablets PL 20075/0215

Batch NumberExpiry DatePack SizeFirst Distributed
Y0690909/20216004 October 2019
X2160205/20216007 April 2019
X1964903/20216003 July 2019
X1986603/20216011 June 2019

Atrolak XL 400mg prolonged release tablets PL 20075/0216

Batch NumberExpiry DatePack SizeFirst Distributed
X2182505/20216010 October 2019
X1876503/20216005 July 2019

More For You

Call to improve inclusivity in clinical research

Ethnic minority adults continue to be underrepresented in clinical trials.

iStock

Call to improve inclusivity in clinical research

A NEW report has called for the participation of a wide range of diverse communities in clinical research to make sure that the medicines meet the needs of the UK's increasingly diverse population.

The report ‘Achieving inclusivity in clinical research’, prepared by the Association of the British Pharmaceutical Industry (ABPI) and the Association of Medical Research Charities (AMRC), highlights the long-standing challenges in ensuring diversity in clinical trials.

Keep ReadingShow less
Pharmacy students Learning Support Fund

Pharmacy students will be included in the Travel and Dual Accommodation Expenses section of the NHS Learning Support Fund.

iStock

Pharmacy students to have access to Learning Support Fund

FOR the first time in England, pharmacy students will be eligible to reimburse travel and accommodation costs while attending placements.

The Department of Health and Social Care confirmed that pharmacy students would finally be included in the Travel and Dual Accommodation Expenses (TDAE) section of the NHS Learning Support Fund (LSF).

Keep ReadingShow less
NHS for robotic surgery

Patients undergoing robotic surgery are able to recover quicker and be discharged sooner.

Pic credit: iStock

NHS pushes for robotic surgery to reduce waiting time, improve outcomes

The NHS is planning to step up robotic surgery over the next decade to reduce waiting time, help in the speed of recovery of patients, and shorter hospital stay.

As per the NHS projections, the number is expected to zoom from 70,000 in 2023/24 to half a million by 2035.

Keep ReadingShow less
Scotland's digital patient care record

The amendment ensures that every person who receives health care or a social service in Scotland will have a digital care record

Pic credit: iStock

Scotland's move to create digital patient care record hailed

The Royal Pharmaceutical Society (RPS) in Scotland has welcomed the decision of the Scottish Parliament to create an integrated digital patient care record.

The move came during a debate on the Care Reform (Scotland) Bill on Tuesday (10), when Jackie Baillie tabled an amendment to ensure that every person who receives health care or a social service in Scotland has a digital care record.

Keep ReadingShow less
A woman using a period tracker app

Cambridge University academics have flagged concerns over the safety of period tracker apps

Pic credit: iStock

Users of period tracking apps face privacy, safety risk, say experts

The report said the apps provide a "gold mine" of data for consumer profiling and warn that in the wrong hands it could pose a safety risk

CAMBRIDGE UNIVERSITY academics have flagged concerns over the safety of period tracker apps and warned that the women using them could face privacy and safety risks.

Keep ReadingShow less